Home/Pipeline/ALLAY-HF

ALLAY-HF

Heart Failure with Preserved Ejection Fraction (HFpEF)

Pivotal TrialActive

Key Facts

Indication
Heart Failure with Preserved Ejection Fraction (HFpEF)
Phase
Pivotal Trial
Status
Active
Company

About Alleviant Medical

Alleviant Medical is an innovative, clinical-stage medical device company pioneering a no-implant interatrial shunt therapy for heart failure. Its core technology, the Alleviant System, is a catheter-based device that creates a small, pressure-relieving passage between the heart's atria, aiming to improve symptoms and quality of life for patients who remain symptomatic despite optimal medical therapy. The company is advancing its technology through two pivotal clinical trials and operates as a pre-revenue, private entity backed by venture capital. If successful, Alleviant's implant-free approach could differentiate it in the growing market for heart failure interventional devices.

View full company profile

Therapeutic Areas

Other Heart Failure with Preserved Ejection Fraction (HFpEF) Drugs

DrugCompanyPhase
Barostim™CVRxClinical Feasibility
MANPE-Star BioTechPhase 1/2
PEGylated Pirfenidonei-CordisPre-clinical
VS-041Vasa TherapeuticsPhase 1
Neucardin®Zensun Sci & TechPhase 2
SAVM ProcedureAxon TherapiesPhase 2
SRD001 (inferred)SardocorPhase 1
STM-01Secretome TherapeuticsPhase 1